On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Stichting Tuberculosis Vaccine Initiative's own share of each project, not the project's full budget.
- Horizon Europe€3.7M · 5 projects
- Horizon 2020€2.5M · 2 projects
- FP7 (2007 to 2013)€2.1M · 6 projects
- Erasmus+ (ERASMUS+)€0 · 1 project
Projects
14 EU-funded projects, newest first. Stichting Tuberculosis Vaccine Initiative led 5 of them as coordinator. Each links to the official record.
- ACTTIVACCoordinator
A Phase 2a Randomised Clinical Trial to Identify the Optimal Dose of the Thermostable ID93+GLA-SE Tuberculosis Vaccine for Further Clinical Evaluation and Local Manufacture in Africa
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€825ktheir share - T5-TBVACPartner
EVALUATING A MULTI-VALENT AEROSOL BOOSTER TB VACCINE FOR ADOLESCENTS AND YOUNG ADULTS IN DIVERSE AFRICAN SETTINGS: T5 TBVAC
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€669ktheir share - MTBVAC-AVANTEPartner
Advancing a Vaccine for Adolescent/Adult and Neonatal TB Epidemic
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€1.2Mtheir share - LIVE_InnovAssociated partner
Leading International Vaccinology Education for Innovation
Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗
- ITHEMYCCoordinator
Novel immunotherapies for tuberculosis and other mycobacterial diseases
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€508ktheir share - TBVAC-HORIZONCoordinator
Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€500ktheir share - STriTuVaDPartner
In Silico Trial for Tuberculosis Vaccine Development
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€66ktheir share - TBVAC2020Coordinator
TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€2.5Mtheir share - EURIPREDPartner
European Research Infrastructures for Poverty Related Diseases
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€367ktheir share - €193ktheir share
- NEWTBVACCoordinator
Discovery and preclinical development of new generation tuberculosis vaccines
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€1.1Mtheir share - TRANSVACPartner
European Network of Vaccine Development and Research
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€85ktheir share - INYVAXPartner
Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges
FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗
€49ktheir share - ESI-TBVIPartner
Establishment, Strategy and Initial activities of the TuBerculosis Vaccine Initiative : Coordination of European efforts with global research initiatives
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
€313ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 8 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 6 shared projects
- London School of Hygiene and Tropical Medicine Royal CharterUnited Kingdom · 6 shared projects
- Statens Serum InstitutDenmark · 6 shared projects
- Department of HealthUnited Kingdom · 6 shared projects
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 5 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 5 shared projects
- Stichting Biomedical Primate Research CenterNetherlands · 5 shared projects
- Universite de GeneveSwitzerland · 4 shared projects
- Institut PasteurFrance · 4 shared projects
- Universidad de ZaragozaSpain · 4 shared projects
- Glaxosmithkline Biologicals SABelgium · 4 shared projects
- Institut de Investigacio en Ciencies de la Salut Germans Trias i PujolSpain · 4 shared projects
- Universite Libre de BruxellesBelgium · 3 shared projects
- Universite de LausanneSwitzerland · 3 shared projects
- Universitaet UlmGermany · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- HIV
- antibiotic resistance
- antibiotics
- drug discovery
- drug resistance
- employment
- genetics
- immunisation
- immunology
- immunotherapy
- infectious diseases
- malaria
- multidrug resistance
- pandemics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
